Radioisotope synovectomy in the treatment of patients with rheumatoid arthritis

In a number of cases, systemic therapy for rheumatoid arthritis (RA), including disease-modifying anti-rheumatic drugs, biological agents, glucocorticoids (GCs), and nonsteroidal anti-inflammatory drugs, fails to completely suppress joint inflammatory changes in the patients. Therefore, local method...

Full description

Saved in:
Bibliographic Details
Main Authors: R. M. Balabanova, Yu. A. Olyunin, A. M. Lila
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2019-03-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/894
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849691612049833984
author R. M. Balabanova
Yu. A. Olyunin
A. M. Lila
author_facet R. M. Balabanova
Yu. A. Olyunin
A. M. Lila
author_sort R. M. Balabanova
collection DOAJ
description In a number of cases, systemic therapy for rheumatoid arthritis (RA), including disease-modifying anti-rheumatic drugs, biological agents, glucocorticoids (GCs), and nonsteroidal anti-inflammatory drugs, fails to completely suppress joint inflammatory changes in the patients. Therefore, local methods are widely used in the combination therapy of RA. Intra-articular injection of hyaluronic acid (HA) is a highly local treatment modality. HA can be used as initial therapy when it is necessary to achieve rapid clinical improvement, or at a later stage of the disease, in exacerbation of arthritis. However, in some patients the effect of intra-articular HA can be short-lasting, and a favorable result can be obtained with local radiotherapy. It is based on powerful irradiation of the inflamed synovium, which is provided by intra-articular injection of radioactive isotope colloids. In Russia, RA was successfully treated with colloidal Au-198, but its production was ceased in the 1990s, and agents for radioisotope synovectomy have been long unavailable.Tungsten-188/Rhenium-188generator has been recently designed in Russia, which allows Rhenium-188 to be obtained in clinics. Preclinical trials have shown that intra-articular injection ensures good fixation of the drug in the knee joint with its insignificant accumulation in the liver and other non-target organs and tissues. Introduction of this drug into routine clinical practice can markedly improve the efficiency of treatment in patients with chronic arthritis.
format Article
id doaj-art-5d5d2f24e59e498b8e904bc7ee22a20f
institution DOAJ
issn 1996-7012
2310-158X
language Russian
publishDate 2019-03-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj-art-5d5d2f24e59e498b8e904bc7ee22a20f2025-08-20T03:20:59ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2019-03-0113110110710.14412/1996-7012-2019-1-101-1072155Radioisotope synovectomy in the treatment of patients with rheumatoid arthritisR. M. Balabanova0Yu. A. Olyunin1A. M. Lila2V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyIn a number of cases, systemic therapy for rheumatoid arthritis (RA), including disease-modifying anti-rheumatic drugs, biological agents, glucocorticoids (GCs), and nonsteroidal anti-inflammatory drugs, fails to completely suppress joint inflammatory changes in the patients. Therefore, local methods are widely used in the combination therapy of RA. Intra-articular injection of hyaluronic acid (HA) is a highly local treatment modality. HA can be used as initial therapy when it is necessary to achieve rapid clinical improvement, or at a later stage of the disease, in exacerbation of arthritis. However, in some patients the effect of intra-articular HA can be short-lasting, and a favorable result can be obtained with local radiotherapy. It is based on powerful irradiation of the inflamed synovium, which is provided by intra-articular injection of radioactive isotope colloids. In Russia, RA was successfully treated with colloidal Au-198, but its production was ceased in the 1990s, and agents for radioisotope synovectomy have been long unavailable.Tungsten-188/Rhenium-188generator has been recently designed in Russia, which allows Rhenium-188 to be obtained in clinics. Preclinical trials have shown that intra-articular injection ensures good fixation of the drug in the knee joint with its insignificant accumulation in the liver and other non-target organs and tissues. Introduction of this drug into routine clinical practice can markedly improve the efficiency of treatment in patients with chronic arthritis.https://mrj.ima-press.net/mrj/article/view/894rheumatoid arthritislocal radiotherapyradioisotope synovectomyradiocolloidsynovium
spellingShingle R. M. Balabanova
Yu. A. Olyunin
A. M. Lila
Radioisotope synovectomy in the treatment of patients with rheumatoid arthritis
Современная ревматология
rheumatoid arthritis
local radiotherapy
radioisotope synovectomy
radiocolloid
synovium
title Radioisotope synovectomy in the treatment of patients with rheumatoid arthritis
title_full Radioisotope synovectomy in the treatment of patients with rheumatoid arthritis
title_fullStr Radioisotope synovectomy in the treatment of patients with rheumatoid arthritis
title_full_unstemmed Radioisotope synovectomy in the treatment of patients with rheumatoid arthritis
title_short Radioisotope synovectomy in the treatment of patients with rheumatoid arthritis
title_sort radioisotope synovectomy in the treatment of patients with rheumatoid arthritis
topic rheumatoid arthritis
local radiotherapy
radioisotope synovectomy
radiocolloid
synovium
url https://mrj.ima-press.net/mrj/article/view/894
work_keys_str_mv AT rmbalabanova radioisotopesynovectomyinthetreatmentofpatientswithrheumatoidarthritis
AT yuaolyunin radioisotopesynovectomyinthetreatmentofpatientswithrheumatoidarthritis
AT amlila radioisotopesynovectomyinthetreatmentofpatientswithrheumatoidarthritis